Google Alert - pharmaceutical news

News 9 new results for pharmaceutical news

Patents appeal board rejects AstraZeneca's plea on cancer drug Economic Times Global pharmaceutical companies have suffered a string of defeats in India, where the law amended in 2005 ensures patent protection for new drug compounds but is loath to recognise new forms of existing medicines. Multinational pharma companies, on ... See all stories on this topic » Economic Times

Pharmaceuticals and universities working together on multi million pound project University of Manchester The €26.4 (£21.2M) project, CHEM21, brings together six pharmaceutical companies, 13 Universities and four small to medium enterprises from across Europe. The aim is to develop sustainable biological and chemical alternatives to finite materials, such ... See all stories on this topic » University of Manchester

TEKMIRA PHARMACEUTICALS CORPORATION : Tekmira Acquires Worldwide ... 4-traders VANCOUVER, British Columbia, Nov. 29, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today that it has obtained a worldwide, ... See all stories on this topic »

Irish Economy: Pharmaceutical patent cliff no growth threat; High exports have ... FinFacts Ireland Irish Economy: Given the official mantras on export growth in recent years from ministers, the Department of Finance, the Central Bank of Ireland and the semi-official Economic and Social Research Institute (ESRI), coupled with echoing in Troika ... See all stories on this topic » FinFacts Ireland

REXAHN PHARMACEUTICALS, INC. : Rexahn Pharmaceuticals Prices Public ... 4-traders REXAHN PHARMACEUTICALS, INC. (NYSE MKT: RNN) today announced the pricing of an underwritten public offering of 19,130,435 shares of its common stock and warrants exercisable for up to 10,521,739 additional shares at $0.33 per fixed combination ... See all stories on this topic »

Cadence Pharmaceutical's Patent Settlement Bolsters My Buy Rating Seeking Alpha Cadence Pharmaceuticals (CADX) is up about 6% today on the announcement that it has entered into a settlement with Perrigo (PRGO) on patent litigation regarding Ofirmev is a positive. Uncertainty over the patent situation of Ofirmev has been a dark ... See all stories on this topic »

Healthcare Review: Arena Pharmaceuticals, Rexahn Pharmaceuticals, Nymox ... Reuters Arena Pharmaceuticals, Inc.(ARNA) enters into a co-development and license agreement with Ildong Pharmaceutical for Temanogrel, ARNA's treatment for myocardial infarction, acute coronary syndrome, stroke, peripheral artery disease, and other ... See all stories on this topic »

NanoPass Technologies Grants a Commercial License to Janssen ... Sacramento Bee Yotam Levin, Chief Executive Officer of NanoPass, said, "We are delighted to enter into this license agreement with Janssen, a leading pharmaceutical company. We see a significant opportunity for improving immunogenicity and/or reducing the dose of ... See all stories on this topic »

Pharmaceutical Marketing Ideas and Strategy from ByReputation's New ... Equities.com With the use of organic search engine optimization, local search directories, and content marketing, ByReputation is putting forth a new pharmaceutical marketing service to help patients obtain more services. To get a free pharmaceutical marketing ... See all stories on this topic »

---

Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.